Results 11 to 20 of about 1,214,442 (354)

Ondine’s curse: the origin of the myth [PDF]

open access: yesArquivos de Neuro-Psiquiatria, 2020
Central alveolar hypoventilation syndrome has been known for decades as Ondine’s curse. It was named as such after a German myth. Although most of the stories resemble one another, word of mouth has led to misinterpretation of this tale among the medical
Eduardo Orrego-González   +3 more
doaj   +1 more source

Pulmonary nuclear medicine [PDF]

open access: yesEuropean Journal of Nuclear Medicine, 1992
This article reviews the contribution made by nuclear imaging to the assessment, diagnosis and monitoring of patients with respiratory disease. It focuses on several specific areas including the diagnosis of pulmonary embolism, the investigation of intrapulmonary infection and neoplasm and the role of positron emission tomography (PET) scanning.
Miller, R F, O'Doherty, M J
openaire   +3 more sources

Longitudinal Associations of the Cystic Fibrosis Airway Microbiome and Volatile Metabolites: A Case Study

open access: yesFrontiers in Cellular and Infection Microbiology, 2020
The identification of 16S rDNA biomarkers from respiratory samples to describe the continuum of clinical disease states within persons having cystic fibrosis (CF) has remained elusive.
Andrea Hahn   +15 more
doaj   +1 more source

ATS Core Curriculum 2016: Part III. Pediatric Pulmonary Medicine. [PDF]

open access: greenAnn Am Thorac Soc, 2016
Boyer D   +18 more
europepmc   +3 more sources

The initial experience of COVID-19 vaccination from a tertiary care centre of India

open access: yesMonaldi Archives for Chest Disease, 2021
To the Editor Drugs Controller General of India (DCGI) has approved the Bharat biotech vaccine against COVID-19, which is a locally manufactured inactivated vaccine named ''COVAXIN'' in collaboration with the Indian council of medical research (ICMR ...
RK Srivastava   +2 more
doaj   +1 more source

Nanoparticles in the treatment of chronic lung diseases [PDF]

open access: yes, 2019
Nanoparticles, although considered a topic of modern medicine, actually have an interesting history. Currently, advances in nanomedicine hold great promise as drug carrier systems for sustained release and targeted delivery of diverse therapeutic agents.
Alexescu, Teodora G   +9 more
core   +2 more sources

An analysis of potential costs of adverse events based on Drug Programs in Poland. Pulmonology focus

open access: yesCurrent Issues in Pharmacy and Medical Sciences, 2014
The project was performed within the Polish Society for Pharmacoeconomics (PTFE). The objective was to estimate the potential costs of treatment of side effects, which theoretically may occur as a result of treatment of selected diseases. We analyzed the
Szkultecka-Debek Monika   +9 more
doaj   +1 more source

Baixa prevalência das manifestações extra-articulares renais, cardíacas, pulmonares e neurológicas nas espondiloartrites: análise do Registro Brasileiro de Espondiloartrites Low prevalence of renal, cardiac, pulmonary, and neurological extra-articular clinical manifestations in spondyloarthritis: analysis of the Brazilian Registry of Spondyloarthritis

open access: yesRevista Brasileira de Reumatologia, 2012
OBJETIVO: Descrever as manifestações extra-articulares (cardíacas, renais, pulmonares e neurológicas) geralmente não relacionadas às espondiloartrites (EpA) em uma grande coorte de pacientes brasileiros.
Carlos Ewerton Maia Rodrigues   +32 more
doaj   +1 more source

Home - About - Disclaimer - Privacy